STAMFORD, Conn. (AP) — STAMFORD, Conn. (AP) — Pitney Bowes Inc. (PBI) on Wednesday reported earnings of $52 million in its third quarter. On a per-share basis, the Stamford, Connecticut-based company ...
Oct 27 (Reuters) - BioMarin Pharmaceutical (BMRN.O), opens new tab said on Monday it plans to divest its gene therapy, a product once expected to be a blockbuster treatment for a type of rare bleeding ...
In a deal that could bring more than $2.1 billion in payments to Arbor Biotechnologies Inc., 90-year-old Chiesi Group gained exclusive and global rights to develop and commercialize ABO-101 for ...
After telegraphing an investigation in November, the FDA has moved to restrict the use of bluebird bio’s gene therapy Skysona in certain patients. The FDA has updated Skysona’s indication, allowing it ...
A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies. His work was reviled as reckless and unethical because, ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A St. Louis startup is ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Wilson, CEO of Gemma Bio, called ...
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback